Effect of HGF activator inhibitor type-1 (HAI-1) on cell growth of hepatoma cell lines.

被引：0
|
作者：
Nagata, K
Ido, A
Moriuchi, A
Tahara, Y
Miyata, Y
Uto, H
Hori, T
Shimomura, T
Kataoka, H
Hirono, S
Hayashi, K
Tsubouchi, H
机构：
[1] Miyazaki Med Coll, Miyazaki 88916, Japan
[2] Mitsubishi Chem Corp, Res Ctr, Yokohama, Kanagawa 227, Japan
[3] Miyazaki Med Coll, Miyazaki 88916, Japan
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1295
引用
收藏
页码：483A / 483A
页数：1
相关论文
共 50 条
  • [31] Expression of hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) in ovarian cancer
    Nakamura, Keiichiro
    Abarzua, Fernando
    Kodama, Junichi
    Hongo, Atsushi
    Nasu, Yasutomo
    Kumon, Hiromi
    Hiramatsu, Yuji
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 34 (02) : 345 - 353
  • [32] Loss of hepatocyte growth factor activator inhibitor type 1 (HAI-1) upregulates MMP-9 expression and induces degradation of the epidermal basement membrane
    Liang Weiting
    Makiko Kawaguchi
    Tsuyoshi Fukushima
    Yuichiro Sato
    Human Cell, 38 (1)
  • [33] Hepatocytes growth factor activator type 1 (HAI-1) is augmented in intrahepatic small bile ducts in primary biliary cirrhosis
    Sasaki, M
    Ikeda, H
    Kataoka, H
    Nakanuma, Y
    HEPATOLOGY, 2005, 42 (04) : 468A - 468A
  • [34] TRANSFORMING GROWTH FACTOR-BETA-1 IS A POTENT INDUCER OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN HUMAN GLIOBLASTOMA AND CARCINOMA CELL-LINES
    HELSETH, E
    DALEN, A
    UNSGAARD, G
    SKANDSEN, T
    GRONDAHLHANSEN, J
    LUND, LR
    APMIS, 1988, 96 (09) : 845 - 849
  • [35] Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) are potential targets in uterine leiomyosarcoma
    Nakamura, Keiichiro
    Abarzua, Fernando
    Hongo, Atsushi
    Kodama, Junichi
    Nasu, Yasutomo
    Kumon, Hiromi
    Hiramatsu, Yuji
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 37 (03) : 605 - 614
  • [36] Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines
    Daniela Schilling
    Christine Bayer
    Anneke Geurts-Moespot
    Fred CGJ Sweep
    Martin Pruschy
    Karin Mengele
    Lisa D Sprague
    Michael Molls
    BMC Cancer, 7
  • [37] TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) - CELL-SPECIFIC EXPRESSION AND HORMONAL-REGULATION IN HUMAN CELL-LINES
    LUND, LR
    RICCIO, A
    MAYER, M
    GEORG, B
    DANO, K
    BLASI, F
    ANDREASEN, PA
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (09): : 1551 - 1551
  • [38] Reduced expression of hepatocyte growth factor (HGF) activator inhibitor type-1 and enhanced activation of HGF in the early stage gastrointestinal carcinomas.
    Kataoka, H
    Itoh, H
    Hamasuna, R
    Kitamura, N
    Koono, M
    GASTROENTEROLOGY, 2000, 118 (04) : A277 - A277
  • [39] Defect of Hepatocyte Growth Factor Activator Inhibitor Type 1/Serine Protease Inhibitor, Kunitz Type 1 (Hai-1/Spint1) Leads to Ichthyosis-Like Condition and Abnormal Hair Development in Mice
    Nagaike, Koki
    Kawaguchi, Makiko
    Takeda, Naoki
    Fukushima, Tsuyoshi
    Sawaguchi, Akira
    Kohama, Kazuyo
    Setoyama, Mitsuru
    Kataoka, Hiroaki
    AMERICAN JOURNAL OF PATHOLOGY, 2008, 173 (05): : 1464 - 1475
  • [40] Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading
    Planus, E
    BarlovatzMeimon, G
    Rogers, RA
    Bonavaud, S
    Ingber, DE
    Wang, N
    JOURNAL OF CELL SCIENCE, 1997, 110 : 1091 - 1098
12345